This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Graham (GHM) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Graham (GHM) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Splunk (SPLK) Outpaces Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Splunk (SPLK) beats fiscal second-quarter earnings and revenue estimates, backed by efficiencies within its own internal operation and healthy customer engagement.
New Strong Buy Stocks for August 24th
by Zacks Equity Research
GHM, MBWM, BRT, WTTR, and CDNS have been added to the Zacks Rank #1 (Strong Buy) List on August 24, 2022.
Graham (GHM) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Graham (GHM) delivered earnings and revenue surprises of 175% and 3.07%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Dover Corporation (DOV) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Dover Corporation (DOV) delivered earnings and revenue surprises of 2.88% and 0.71%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Strength Seen in Graham (GHM): Can Its 7.4% Jump Turn into More Strength?
by Zacks Equity Research
Graham (GHM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Strength Seen in Xometry (XMTR): Can Its 9.1% Jump Turn into More Strength?
by Zacks Equity Research
Xometry (XMTR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Graham (GHM) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Graham (GHM) delivered earnings and revenue surprises of 33.33% and 4.57%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
RBC Bearings (ROLL) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
RBC Bearings (ROLL) delivered earnings and revenue surprises of 18.87% and 2.61%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Columbus McKinnon (CMCO) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Columbus McKinnon (CMCO) delivered earnings and revenue surprises of 1.28% and 7.75%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Nordson (NDSN) Q2 Earnings Beat Estimates
by Zacks Equity Research
Nordson (NDSN) delivered earnings and revenue surprises of 7.05% and 0.71%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock?
Applied DNA Sciences (APDN) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 6.67% and 32.19%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Eos Energy Enterprises, Inc. (EOSE) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Eos Energy Enterprises, Inc. (EOSE) delivered earnings and revenue surprises of -54.55% and 21.76%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for March 24th
by Zacks Equity Research
GHM, AMRS, and GDOT have been added to the Zacks Rank #5 (Strong Sell) List on March 24, 2022
New Strong Sell Stocks for February 11th
by Zacks Equity Research
ALGN, CNHI, EPC, GHM, and HNGR have been added to the Zacks Rank #5 (Strong Sell) List on February 11, 2022.
Graham (GHM) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Graham (GHM) delivered earnings and revenue surprises of -212.50% and 24.28%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Xylem (XYL) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Xylem (XYL) delivered earnings and revenue surprises of 1.61% and 2.29%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Roper Technologies (ROP) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Roper Technologies (ROP) delivered earnings and revenue surprises of 1.91% and 0.65%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Graham (GHM) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Graham (GHM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Graham's (GHM) QTD Orders Worth $20M to Boost FY22 Revenues
by Zacks Equity Research
Graham's (GHM) orders of $20 million so far in second-quarter fiscal 2022 reflect improving demand, mainly in the defense market. Awarded contracts are to contribute to fiscal 2022 revenues.
Graham (GHM) Boosts Defense Business With Barber-Nichols Buyout
by Zacks Equity Research
Graham's (GHM) buyout of Barber-Nichols is anticipated to enhance the company's business in the defense sector. The acquisition is expected to be accretive to revenues and earnings in fiscal 2022.
Graham (GHM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Graham (GHM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Graham (GHM) Q3 Earnings Lag Estimates
by Zacks Equity Research
Graham (GHM) delivered earnings and revenue surprises of -8.33% and 9.58%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Manufacturing Revenues Poised to Increase: 5 Solid Picks
by Ritujay Ghosh
Steady growth in manufacturing activity is expected through 2021 and is likely to help companies like ParkerHannifin Corporation (PH), AGCO Corporation (AGCO) and Graco (GGG).
Colfax's (CFX) Unit Closes Buyout of Trilliant Surgical
by Zacks Equity Research
Colfax (CFX) arm DJO closes buyout of Trilliant Surgical, which will boost its product offerings and growth prospects in the foot and ankle surgery market.